As a first indicator for a potential relevance of PRMT1 and PRMT5 in ES, we queried the R2 platform for PRMT1 and PRMT5 mRNA expression focusing on the Filion dataset which includes ES alongside other fusion-positive sarcomas (32). The gene discussed is PRMT5; the disease is sarcoma.